Eris Lifesciences vs Akums Drugs vs Innova Captab: Which Stock Should You Track

Eris Lifesciences vs Akums Drugs and Pharmaceuticals vs Innova Captab starts with the core numbers most investors compare within the Pharma Formulations segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.

All three names sit in the Pharma Formulations bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.

Click Here – Get Free Investment Predictions

Eris Lifesciences, Akums Drugs and Pharmaceuticals and Innova Captab: Company Overview

Eris Lifesciences is a listed Indian company in the Pharma Formulations space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Akums Drugs and Pharmaceuticals is a listed Indian company in the Pharma Formulations space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Innova Captab is a listed Indian company in the Pharma Formulations space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Eris Lifesciences vs Akums Drugs and Pharmaceuticals vs Innova Captab: Valuation and Profitability Snapshot

Metric	Eris Lifesciences	Akums Drugs and Pharmaceuticals	Innova Captab
Market Cap (approx.)	Rs 17,490 crore	Rs 12,891 crore	Rs 7,336 crore
PE Ratio (TTM)	26.27	44.03	47.62
PB Ratio	4.48	3.89	6.73
Return on Equity (ROE)	15.87%	7.70%	12.92%
EPS (TTM, Rs)	47.98	18.60	26.92
Dividend Yield	0.57%	0.36%	0.16%
Debt to Equity	0.60	0.05	0.32
Book Value per Share (Rs)	281.30	210.57	190.61

Check the Univest Screener for Live Data

On valuation, Eris Lifesciences trades at a PE of 26.27 and a PB of 4.48, Akums Drugs and Pharmaceuticals at a PE of 44.03 and a PB of 3.89, while Innova Captab trades at a PE of 47.62 and a PB of 6.73. On return on equity, the three post 15.87%, 7.70% and 12.92% respectively, and on dividend yield they stand at 0.57%, 0.36% and 0.16%.

Eris Lifesciences vs Akums Drugs and Pharmaceuticals vs Innova Captab: Latest Quarterly Results

Company	Latest Quarter Revenue	Latest Quarter Net Profit	YoY Change (Revenue)	QoQ Change (Revenue)
Eris Lifesciences	Rs 875.64 crore	Rs 143.32 crore	+12.9%	+15.4%
Akums Drugs and Pharmaceuticals	Rs 1,197.01 crore	Rs 100.98 crore	+13.9%	+0.3%
Innova Captab	Rs 472.86 crore	Rs 44.13 crore	+32.8%	+5.2%

Quarterly figures above are the most recent reported quarter for each company (Q1 FY27, quarter ended June 2026), compared with the year-ago and preceding quarter.

Download the Univest iOS App or Univest Android App to track Eris Lifesciences, Akums Drugs and Pharmaceuticals and Innova Captab live prices.

What Should Investors Look at Beyond These Numbers?

Beyond the metrics above, investors comparing these three pharma formulations names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.

Conclusion

Eris Lifesciences vs Akums Drugs and Pharmaceuticals vs Innova Captab highlights how differently three companies in the same pharma formulations segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.

FAQs on Eris Lifesciences vs Akums Drugs and Pharmaceuticals vs Innova Captab

What is the market cap difference between Eris Lifesciences, Akums Drugs and Pharmaceuticals and Innova Captab?

Ans. As of September 2026, Eris Lifesciences has a market cap of approximately Rs 17,490 crore, Akums Drugs and Pharmaceuticals is at approximately Rs 12,891 crore, and Innova Captab is at approximately Rs 7,336 crore.

Which of the three has the highest PE ratio?

Ans. Among Eris Lifesciences, Akums Drugs and Pharmaceuticals and Innova Captab, the PE ratios stand at 26.27, 44.03 and 47.62 respectively as of September 2026.

Which of the three has the highest ROE?

Ans. Eris Lifesciences, Akums Drugs and Pharmaceuticals and Innova Captab post ROE of 15.87%, 7.70% and 12.92% respectively as of September 2026.

Which of these three stocks pays the highest dividend yield?

Ans. Eris Lifesciences, Akums Drugs and Pharmaceuticals and Innova Captab carry dividend yields of 0.57%, 0.36% and 0.16% respectively.

What is the debt to equity ratio for Eris Lifesciences, Akums Drugs and Pharmaceuticals and Innova Captab?

Ans. Eris Lifesciences carries a debt to equity of 0.60, Akums Drugs and Pharmaceuticals of 0.05, and Innova Captab of 0.32.

Which of the three trades at the highest price to book value?

Ans. Eris Lifesciences, Akums Drugs and Pharmaceuticals and Innova Captab trade at price to book ratios of 4.48, 3.89 and 6.73 respectively.

Is one of Eris Lifesciences, Akums Drugs and Pharmaceuticals or Innova Captab better than the others?

Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor's own criteria and research.